World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
23847
World Ranking
16661
National Ranking
666

Overview

Bruno Vincenzi is affiliated with Università Campus Bio-Medico in Italy, focusing primarily on medical research with a substantial publication record in the field of medicine. Their work spans several prominent subfields including pulmonary and respiratory medicine, oncology, surgery, rheumatology, and molecular biology.

The research topics they frequently address include sarcoma diagnosis and treatment, cardiac tumors and thrombi, lung cancer treatments and mutations, cancer immunotherapy and biomarkers, gastrointestinal tumor research and treatment, COVID-19 and its impacts on healthcare, as well as vascular tumors and angiosarcomas.

Vincenzi has contributed to multiple papers published in well-regarded venues. Some of the notable recent papers include:

  • "Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples," 2020, Journal of Experimental & Clinical Cancer Research
  • "Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors," 2023, New England Journal of Medicine
  • "Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer," 2020, Cancer Discovery
  • "Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study," 2021, The Lancet Oncology
  • "Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group," 2020, Cancer

The scientist has published extensively in several key journals, with frequent appearances in:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • ESMO Open
  • Cancers
  • Precision Cancer Medicine

Collaborations are a notable aspect of Vincenzi's career. Common coauthors include Giuseppe Tonini, Daniele Santini, Alessio Cortellini, Giovanni Grignani, and Francesco Pantano, reflecting an active network of collaboration in oncological and medical research.

Overall, their body of work underscores an engagement with complex clinical and molecular challenges in cancer treatment and diagnosis, as well as investigations into the impacts of COVID-19 on cancer patients and treatment outcomes.

Best Publications

  • Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    Wendy De Roock;Bart Claes;David Bernasconi;Jef De Schutter

  • KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

    F Loupakis;A Ruzzo;C Cremolini;B Vincenzi

  • Zoledronic Acid Induces Significant and Long-Lasting Modifications of Circulating Angiogenic Factors in Cancer Patients

    Daniele Santini;Bruno Vincenzi;Giordano Dicuonzo;Giuseppe Avvisati

  • Pamidronate Induces Modifications of Circulating Angiogenetic Factors in Cancer Patients

    Daniele Santini;Bruno Vincenzi;Giuseppe Avvisati;Giordano Dicuonzo

  • Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients

    Cristina Raimondi;Angela Gradilone;Giuseppe Naso;Bruno Vincenzi

  • High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice.

    Daniele Santini;Fotios Loupakis;Bruno Vincenzi;Irene Floriani

  • Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.

    T C Mineo;V Ambrogi;A Baldi;C Rabitti

  • Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

    D. Santini;B. Vincenzi;R. Addeo;C. Garufi

  • Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients

    Daniele Santini;Bruno Vincenzi;Sara Galluzzo;Fabrizio Battistoni

  • Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib

    Bruno Vincenzi;Daniele Santini;Antonio Russo;Raffaele Addeo

  • The antineoplastic role of bisphosphonates: from basic research to clinical evidence

    D. Santini;U. Vespasiani Gentilucci;B. Vincenzi;A. Picardi

  • Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?

    Giuseppe Badalamenti;Daniele Fanale;Lorena Incorvaia;Nadia Barraco

  • Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples

    Marco Russano;Andrea Napolitano;Giulia Ribelli;Michele Iuliani

  • Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.

    Daniele Santini;Gaia Schiavon;Gaia Schiavon;Bruno Vincenzi;Laura Maria Gaeta

  • Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

    D. J. Pinato;A. Zambelli;A. Bertuzzi;A. Marrari

  • Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients.

    Bruno Vincenzi;Daniele Santini;Giordano Dicuonzo;Fabrizio Battistoni

  • Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance

    Raffaele Addeo;Michele Caraglia;Sergio Bellini;Alberto Abbruzzese

  • Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

    Paola Sperone;Anna Ferrero;Fulvia Daffara;Adriano Priola

  • Pamidronate (P) induces modifications of circulating angiogenetic factors in cancer patients

    D. Santini;B. Vincenzi;G. Di Cuonzo;F. Battistoni

  • KRAS codon 61, 146 and BRAF V600E mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

    A. Ruzzo;F. Loupakis;E. Canestrari;Chiara Cremolini

Frequent Co-Authors

Daniele Santini
Daniele Santini Università Campus Bio-Medico
Giuseppe Tonini
Giuseppe Tonini Università Campus Bio-Medico
Alfonso Baldi
Alfonso Baldi University of Campania "Luigi Vanvitelli"
Antonio Russo
Antonio Russo University of Palermo
Alfredo Falcone
Alfredo Falcone University of Pisa
Michele Caraglia
Michele Caraglia University of Campania "Luigi Vanvitelli"
Fotios Loupakis
Fotios Loupakis Istituto Oncologico Veneto
Paolo G. Casali
Paolo G. Casali University of Milan
Angelo Paolo Dei Tos
Angelo Paolo Dei Tos University of Padua
Silvia Stacchiotti
Silvia Stacchiotti University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional medical education in the USA is demanding—and often costly. However, there are alternative online degrees and career pathways in the health sector that offer flexibility and affordability for aspiring healthcare professionals.

For those interested in health information systems, earning a him associate degree online can open doors to administrative and data roles within the healthcare industry. Another in-demand option is medical billing and coding. Prospective students often want to know how much is medical billing and coding school, and many affordable online programs exist that prepare students for certification and entry-level careers.

Nursing continues to be a popular choice. You can find the cheapest np programs online to advance from registered nurse to nurse practitioner. For those starting out, exploring the cheapest bsn programs online is a cost-effective way to earn a Bachelor of Science in Nursing.

These alternative online pathways offer varied routes into healthcare—making a fulfilling career more accessible, regardless of your starting point.

Best Scientists Citing Bruno Vincenzi

Trending Scientists

Recently Published Articles